SCOPUS 정보 검색 플랫폼

Journal of Hepatology

Volumn 57, Issue 6, 2012, Pages 1368-1369

Rapamycin impacts positively on longevity, despite glucose intolerance induction

(3) Piguet, Anne Christine a Martins, Paulo J F b Kozma, Sara C b,c

a UNIVERSITY OF BERN (Switzerland)

b UNIVERSITY OF CINCINNATI MEDICAL CENTER (United States)

c HOSPITAL UNIVERSITARI DE BELLVITGE (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; MEMBRANE PROTEIN; MLST8 PROTEIN; RAPAMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; FEMALE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HETEROZYGOTE; IN VIVO STUDY; INSULIN SENSITIVITY; LONGEVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 84869217809 PISSN: 01688278 EISSN: None Source Type: Journal
DOI: 10.1016/j.jhep.2012.06.038 Document Type: Note

Times cited : (2)

References (10)

1
- 84859117806
- Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity
- D.W. Lamming, L. Ye, P. Katajisto, M.D. Goncalves, M. Saitoh, and D.M. Stevens Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity Science 335 2012 1638 1643
- (2012) Science , vol.335 , pp. 1638-1643
- Lamming, D.W.¹ Ye, L.² Katajisto, P.³ Goncalves, M.D.⁴ Saitoh, M.⁵ Stevens, D.M.⁶

2
- 34249679614
- MTOR Complex1-S6K1 signaling: At the crossroads of obesity, diabetes and cancer
- S.G. Dann, A. Selvaraj, and G. Thomas mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer Trends Mol Med 13 2007 252 259
- (2007) Trends Mol Med , vol.13 , pp. 252-259
- Dann, S.G.¹ Selvaraj, A.² Thomas, G.³

3
- 4544220704
- Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
- S.H. Um, F. Frigerio, M. Watanabe, F. Picard, M. Joaquin, and M. Sticker Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity Nature 431 2004 200 205
- (2004) Nature , vol.431 , pp. 200-205
- Um, S.H.¹ Frigerio, F.² Watanabe, M.³ Picard, F.⁴ Joaquin, M.⁵ Sticker, M.⁶

4
- 70349669095
- Ribosomal protein S6 kinase 1 signaling regulates mammalian life span
- C. Selman, J.M. Tullet, D. Wieser, E. Irvine, S.J. Lingard, and A.I. Choudhury Ribosomal protein S6 kinase 1 signaling regulates mammalian life span Science 326 2009 140 144
- (2009) Science , vol.326 , pp. 140-144
- Selman, C.¹ Tullet, J.M.² Wieser, D.³ Irvine, E.⁴ Lingard, S.J.⁵ Choudhury, A.I.⁶

5
- 77949318560
- Metabolic reprogramming, caloric restriction and aging
- R.M. Anderson, and R. Weindruch Metabolic reprogramming, caloric restriction and aging Trends Endocrinol Metab 21 2010 134 141
- (2010) Trends Endocrinol Metab , vol.21 , pp. 134-141
- Anderson, R.M.¹ Weindruch, R.²

6
- 33646023695
- Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
- D.D. Sarbassov, S.M. Ali, S. Sengupta, J.H. Sheen, P.P. Hsu, and A.F. Bagley Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Mol Cell 22 2006 159 168
- (2006) Mol Cell , vol.22 , pp. 159-168
- Sarbassov, D.D.¹ Ali, S.M.² Sengupta, S.³ Sheen, J.H.⁴ Hsu, P.P.⁵ Bagley, A.F.⁶

7
- 77953218866
- Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue
- V.P. Houde, S. Brule, W.T. Festuccia, P.G. Blanchard, K. Bellmann, and Y. Deshaies Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue Diabetes 59 2010 1338 1348
- (2010) Diabetes , vol.59 , pp. 1338-1348
- Houde, V.P.¹ Brule, S.² Festuccia, W.T.³ Blanchard, P.G.⁴ Bellmann, K.⁵ Deshaies, Y.⁶

8
- 42449104351
- MTOR Inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes
- M. Fraenkel, M. Ketzinel-Gilad, Y. Ariav, O. Pappo, M. Karaca, and J. Castel mTOR Inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes Diabetes 57 2008 945 957
- (2008) Diabetes , vol.57 , pp. 945-957
- Fraenkel, M.¹ Ketzinel-Gilad, M.² Ariav, Y.³ Pappo, O.⁴ Karaca, M.⁵ Castel, J.⁶

9
- 67650944993
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
- D.E. Harrison, R. Strong, Z.D. Sharp, J.F. Nelson, C.M. Astle, and K. Flurkey Rapamycin fed late in life extends lifespan in genetically heterogeneous mice Nature 460 2009 392 395
- (2009) Nature , vol.460 , pp. 392-395
- Harrison, D.E.¹ Strong, R.² Sharp, Z.D.³ Nelson, J.F.⁴ Astle, C.M.⁵ Flurkey, K.⁶

10
- 0037942739
- Extended longevity in mice lacking the insulin receptor in adipose tissue
- M. Bluher, B.B. Kahn, and C.R. Kahn Extended longevity in mice lacking the insulin receptor in adipose tissue Science 299 2003 572 574
- (2003) Science , vol.299 , pp. 572-574
- Bluher, M.¹ Kahn, B.B.² Kahn, C.R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.